Morning Overview on MSN
A gene-network study says existing drugs might be repurposed to slow human aging
Researchers have screened thousands of approved drugs against a network of 2,358 longevity-linked genes, producing a shortlist of compounds that may slow biological aging without new drug development.
More than a century after Albert Einstein first transformed our understanding of gravity, his general theory of relativity ...
This research assesses data provenance in widely used health datasets, revealing flaws that could undermine clinical prediction models and patient care.
Barchart on MSN
FuelCell just landed a major AI partner. This could be a game changer for FCEL stock.
FuelCell Energy (FCEL) stock is back in the spotlight after the company announced a new partnership with Siemens (SIEGY).
HKeyBio has established HKEY-AI-NAM-Bridgeâ„¢ 1.0, its AI and New Approach Methodologies (NAMs) In Vivo Evidence Bridging Package. The service helps autoimmune and allergy drug-development teams ...
Older patients represent the fastest growing patient group in clinical care. They are a heterogeneous group, for whom evidence for making treatment decisions is often scarce. Important domains for ...
Researchers identified a six-gene signature in microscopic colorectal cancer (CRC) liver metastases that may help predict ...
Difficulties finding the right words during speech affect 25% of MS patients, and often occur alongside broader cognitive ...
SpaceX’s Transporter-17 rideshare mission lifted off carrying 81 payloads into a sun-synchronous orbit, among them is the world’s first commercial nuclear-powered satellite.
PALO ALTO, CA / ACCESS Newswire / July 9, 2026 / Bioz, Inc., the AI platform that leverages peer-reviewed publications to ...
Integer Technologies, a leading provider of mission assurance and reliability software for maritime operations, announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results